A pragmatic dementia risk score for patients with mild cognitive impairment in a memory clinic population:

Meng Wang1,2,3, Tolulope T Sajobi1,2,3,4, Zahinoor Ismail1,2,5,3,4

  • 1Department of Community Health Sciences University of Calgary Calgary Alberta Canada.

Abstract

Insights

A new dementia risk score, CIDER, accurately predicts dementia in individuals with mild cognitive impairment (MCI). This tool aids clinicians and patients in understanding dementia progression probabilities.

Area of Science:

  • Neurology
  • Geriatrics
  • Cognitive Science

Background:

  • Mild cognitive impairment (MCI) is a transitional stage between normal aging and dementia.
  • Accurate prediction of dementia progression in MCI patients is crucial for timely intervention.
  • Existing risk prediction models often lack validation in diverse clinical settings.

Purpose of the Study:

  • To develop and validate a 3-year dementia risk score for individuals with MCI.
  • To utilize variables commonly collected in routine clinical care for the risk score.
  • To assess the score's predictive performance in independent validation cohorts.

Main Methods:

  • The Mild Cognitive Impairment to Dementia Risk (CIDER) score was developed using data from the National Alzheimer's Coordinating Center (NACC).
  • Cox models were employed for prediction and validated using the Prospective Registry of Persons with Memory Symptoms (PROMPT) and Alzheimer's Disease Neuroimaging Initiative (ADNI) databases.
  • Inclusion criteria focused on individuals aged 55 years and older with MCI.

Main Results:

  • The CIDER score demonstrated good predictive accuracy, with c-indices of 0.69 (internal validation), 0.61 (PROMPT), and 0.72 (ADNI).
  • The score showed consistent performance across internal and external validation cohorts.
  • Confidence intervals indicated statistically significant predictive power.

Conclusions:

  • The CIDER score provides a reliable tool for estimating 3-year dementia risk in MCI patients.
  • This score can inform clinical decision-making and patient counseling regarding dementia progression.
  • The CIDER score's validation in multiple cohorts supports its potential for broad clinical application.